A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

So, we marked another World Sickle Cell Day on Thursday, June 19. But truthfully, what was there to celebrate? I can’t speak for everyone, but I know I speak for many when I say: we have nothing.

Sickle cell disease (SCD) is a condition that directly affects the way the red blood cells of the body carry oxygen. This can lead to further complications. In an interview with HT Lifestyle, Dr Vikas ...

To mark four years of sharing his experiences through writing, columnist Dunstan Nicol-Wilson reflects on the journey with gratitude.

Two rival CAR-Ts are currently approved by the FDA for relapsed or refractory B-cell precursor ALL, namely Novartis' Kymriah (tisagenlecleucel) and Gilead/Kite's Tecartus (brexacabtagene ...